Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Journal article published in 2016 by
This paper was not found in any repository, but could be made available legally by the author.
Preprint: archiving allowed
Data provided by